Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:FLKS

Flex Pharma (FLKS) Stock Price, News & Analysis

Flex Pharma logo

About Flex Pharma Stock (NASDAQ:FLKS)

Advanced Chart

Key Stats

Today's Range
$0.73
$0.92
50-Day Range
$0.57
$14.51
52-Week Range
$0.26
$1.49
Volume
5.63 million shs
Average Volume
2.03 million shs
Market Capitalization
$14.15 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive FLKS Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Flex Pharma and its competitors with MarketBeat's FREE daily newsletter.

FLKS Stock News Headlines

FLEX LNG: A Bond-Like 11.9% Yield To Lock Before Rate Cuts
FLEX LNG Ltd. (FLNG) Q2 2024 Earnings Call Transcript
[No Brainer Gold Play]: “Show me a better investment.”
A Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the quiet buildup behind the scenes. Now, in just days, the floodgates are set to open. The greatest investor of all time could validate what Garrett Goggin has been saying for months: Gold is entering a once-in-a-generation mania. Front-running Buffett has never been more urgent — and four tiny miners could be your ticket to 100X gains.
Wayfair Inc. (W) Q2 2024 Earnings Call Transcript
Q2 2024 AGCO Corp Earnings Call
Flex Ltd. (FLEX) Q1 2025 Earnings Call Transcript
Flex Ltd.: Undervalued With Solid Fundamentals
See More Headlines

FLKS Stock Analysis - Frequently Asked Questions

Flex Pharma Inc (NASDAQ:FLKS) announced its quarterly earnings data on Wednesday, May, 1st. The biotechnology company reported ($0.12) EPS for the quarter. The biotechnology company had revenue of $0.11 million for the quarter. Flex Pharma had a negative trailing twelve-month return on equity of 98.04% and a negative net margin of 1,208.42%.

Flex Pharma (FLKS) raised $60 million in an initial public offering (IPO) on Thursday, January 29th 2015. The company issued 4,600,000 shares at a price of $12.00-$14.00 per share. Jefferies and Piper Jaffray served as the underwriters for the IPO and JMP Securities, Cantor Fitzgerald and Roth Capital Partners were co-managers.

Based on aggregate information from My MarketBeat watchlists, some other companies that Flex Pharma investors own include Micron Technology (MU), Ocular Therapeutix (OCUL), SCYNEXIS (SCYX), Idera Pharmaceuticals (IDRA), Celldex Therapeutics (CLDX), Gilead Sciences (GILD) and Histogenics (HSGX).

Company Calendar

Last Earnings
5/01/2019
Today
7/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Pharmaceutical Preparations
Sub-Industry
N/A
Current Symbol
NASDAQ:FLKS
CIK
1615219
Fax
N/A
Employees
4
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$21.92 million
Net Margins
-1,208.42%
Pretax Margin
N/A
Return on Equity
-98.04%
Return on Assets
-83.37%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
6.86
Quick Ratio
6.74

Sales & Book Value

Annual Sales
$840 thousand
Price / Sales
16.84
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$0.51 per share
Price / Book
1.53

Miscellaneous

Outstanding Shares
18,070,000
Free Float
N/A
Market Cap
$14.15 million
Optionable
Not Optionable
Beta
1.65
Ten Starter Stocks For Beginners to Buy Now Cover

Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.

Get This Free Report

This page (NASDAQ:FLKS) was last updated on 7/31/2025 by MarketBeat.com Staff
From Our Partners